Cited by 55Medicinal Plant Extracts EffectsMedicinal Plants and NeuroprotectionMedicinal Plant Research

Interaction of plant extracts with central nervous system receptors

Open access
Lundstrom, Kenneth, Pham, Huyen, Dinh, Long·2017·Medicines

Abstract

Background: Plant extracts have been used in traditional medicine for the treatment of various maladies including neurological diseases. Several central nervous system receptors have been demonstrated to interact with plant extracts and components affecting the pharmacology and thereby potentially playing a role in human disease and treatment. For instance, extracts from Hypericum perforatum (St. John’s wort) targeted several CNS receptors. Similarly, extracts from Piper nigrum, Stephania cambodica, and Styphnolobium japonicum exerted inhibition of agonist-induced activity of the human neurokinin-1 receptor. Methods: Different methods have been established for receptor binding and functional assays based on radioactive and fluorescence-labeled ligands in cell lines and primary cell cultures. Behavioral studies of the effect of plant extracts have been conducted in rodents. Plant extracts have further been subjected to mood and cognition studies in humans. Results: Mechanisms of action at molecular and cellular levels have been elucidated for medicinal plants in support of standardization of herbal products and identification of active extract compounds. In several studies, plant extracts demonstrated affinity to a number of CNS receptors in parallel indicating the complexity of this interaction. In vivo studies showed modifications of CNS receptor affinity and behavioral responses in animal models after treatment with medicinal herbs. Certain plant extracts demonstrated neuroprotection and enhanced cognitive performance, respectively, when evaluated in humans. Noteworthy, the penetration of plant extracts and their protective effect on the blood-brain-barrier are discussed. Conclusion: The affinity of plant extracts and their isolated compounds for CNS receptors indicates an important role for medicinal plants in the treatment of neurological disorders. Moreover, studies in animal and human models have confirmed a scientific basis for the application of medicinal herbs. However, additional investigations related to plant extracts and their isolated compounds, as well as their application in animal models and the conducting of clinical trials, are required.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/medicines4010012

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [25]Dinh L.D. Ngyuen L.A. Trinh C.T. Pham H.T. Interaction of various Vietnamese medicinal plant extracts with angiotensin II receptor revealed by fluorescein-labeled ligand receptor binding assays Proceedings of the 7th Indochina Conference on Pharmaceutical Sciences and Advancing Pharmacy for ASEAN Community Bangkok, Thailand 14–16 December 2011 P-BB-08

Cited by

Sorted by citations

Authors
Lundstrom, K., Pham, H., & Dinh, L.
Affiliations
  • PanTherapeutics, 1095 Lutry, Switzerland
  • Ministry of Health (VN)
  • Vietnam National University, Hanoi (VN)
Corresponding author
Lundstrom, Kenneth
Venue
Medicines
Publisher
MDPI AG
Published
2017-02-23
Volume
4
Issue
1
Pages
12
ISSN
2305-6320 (ISSN-L)
OpenAlex
W2589505346
Cited by
55
References
64
Citations by year
2026: 5 · 2025: 6 · 2024: 6 · 2023: 8 · 2022: 4 · 2021: 10 · 2020: 6 · 2019: 5 · 2018: 5
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • Medicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
Keywords
plant extracts, central nervous system receptors, medicinal plants, neurokinin-1 receptor, Hypericum perforatum, black pepper, Styphnolobium japonicum, neuroprotection, cognitive enhancement, blood-brain barrier, receptor binding assay, herbal medicine standardization, neurological disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review